title: Is there a difficulty in maintaining haemoglobin target levels in pre-dialysis patients treated with erythropoiesis-stimulating agents?
authors.forename: Eugènia
authors.initials: E
authors.lastname: Santacana-Juncosa
authors.forename: Núria
authors.initials: N
authors.lastname: Padullés-Zamora
authors.forename: Ariadna
authors.initials: A
authors.lastname: Padullés-Zamora
authors.forename: Dolors
authors.initials: D
authors.lastname: Comas-Sugrañes
authors.forename: Lorena
authors.initials: L
authors.lastname: Santulario-Verdú
authors.forename: Núria
authors.initials: N
authors.lastname: Sanmartí-Martínez
authors.forename: Alberto
authors.initials: A
authors.lastname: Martínez-Castelao
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D005260:Female; D019983:Guideline Adherence / Q000706:statistics & numerical data; D006397:Hematinics / Q000627:therapeutic use*; D006454:Hemoglobins / Q000032:analysis*; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D051436:Renal Insufficiency, Chronic / Q000097:blood / Q000150:complications; D012189:Retrospective Studies; D055815:Young Adult
chemical_list: D006397:Hematinics; D006454:Hemoglobins